Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation

SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Akorn, Inc. AKRX shares.

Investors who purchased shares of Akorn, Inc. AKRX in March 2017 or earlier and continue to hold NASDAQ: AKRX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.



On March 8, 2018, a lawsuit was filed against Akorn, Inc. over alleged securities laws violations. The plaintiff claims that the defendants made materially false and/or misleading statements and/or failed to disclose that: Akorn's failure to comply with FDA data integrity requirements would jeopardize Fresenius's acquisition of Akorn, that Akorn lacked effective internal controls over financial reporting, and that as a result, Akorn's financial statements were materially false and misleading at all relevant times.



Those who purchased Akorn, Inc. AKRX shares should contact the Shareholders Foundation, Inc.



The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.



CONTACT:

Shareholders Foundation, Inc. 

Michael Daniels 

+1 (858) 779-1554 

mail@shareholdersfoundation.com 

3111 Camino Del Rio North 

Suite 423 

San Diego, CA 92108

Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsLegalPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!